The symptoms of pancreatic cancer can be easily mistaken for other less serious conditions at first, meaning that it’s typically diagnosed when the disease is at an advanced stage when there are very limited treatment options. Professor Kevin Ryan in Glasgow is looking for molecular clues or ‘markers’ in samples of blood and urine that could be used to detect early pancreatic cancer. These markers will then be validated by comparing patient samples to healthy samples.